🇺🇸 Captopril Tablets in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 13

Most-reported reactions

1. Asthenia — 2 reports (15.38%)
2. Electrolyte Imbalance — 2 reports (15.38%)
3. Weight Decreased — 2 reports (15.38%)
4. Abdominal Pain — 1 report (7.69%)
5. Angioedema — 1 report (7.69%)
6. Anuria — 1 report (7.69%)
7. Blood Pressure Decreased — 1 report (7.69%)
8. Cardiac Failure Acute — 1 report (7.69%)
9. Cardiomegaly — 1 report (7.69%)
10. Cerebrovascular Accident — 1 report (7.69%)

Source database →

Frequently asked questions

Is Captopril Tablets approved in United States?

Captopril Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Captopril Tablets in United States?

Ain Shams University is the originator. The local marketing authorisation holder may differ — check the official source linked above.